Design Considerations for Pharmacokinetic Studies During Pregnancy

Area of Science:

• Pharmacology
• Obstetrics
• Maternal-Fetal Medicine

Background:

• Drug administration is common in obstetrics.
• Pregnant individuals exhibit unique physiological and pharmacological differences compared to non-pregnant adults.
• Standard drug dosages may be unsafe or ineffective during pregnancy.

Purpose of the Study:

• To address the challenges in designing pharmacokinetic studies during pregnancy.
• To provide guidance on establishing appropriate drug dosing regimens for pregnant patients and their fetuses.

Main Methods:

• Discussing unique design considerations for pharmacokinetic studies in pregnancy.
• Evaluating maternal and fetal drug exposure.
• Recognizing pregnancy as a dynamic physiological state.

Main Results:

• Exploration of timing for drug sampling during pregnancy.
• Analysis of control group selection.
• Comparison of dedicated vs. nested pharmacokinetic studies.
• Consideration of single-dose vs. multiple-dose analyses.
• Strategies for dose selection.
• Integration of pharmacodynamic changes.

Conclusions:

• Pharmacokinetic studies in pregnancy require specialized designs to ensure maternal and fetal safety.
• Careful consideration of study design elements is crucial for generating reliable drug dosing data in pregnant populations.